z-logo
Premium
Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia
Author(s) -
Ebadi Maryam,
Wasko Justin,
Weisdorf Daniel J.,
Gordon Peter M.,
Rashidi Armin
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16142
Subject(s) - medicine , cytarabine , vincristine , acute lymphocytic leukemia , mitoxantrone , chemotherapy , methotrexate , rituximab , etoposide , cyclophosphamide , oncology , leukemia , lymphoma , lymphoblastic leukemia

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom